Norepinephrine Bitartrate In Sodium Chloride Injection, Solution
Product Images NDC 44567-641

5 FDA label images from Wg Critical Care, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate In Sodium Chloride (NDC 44567-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Structural)

Structural Formula (Structural)
Chemical structure of norepinephrine bitartrate, showing the molecular components with associated functional groups and hydration.*
FDA Label Image

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 4 mg Per 250 mL Bag Image (Image 01)

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 4 mg Per 250 mL Bag Image (Image 01)
Label for Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, containing 4 mg per 250 mL (16 mcg per mL). This intravenous solution is marked as a high alert medication, labeled for single-dose use with warnings regarding administration and storage, manufactured for WG Critical Care, LLC, made in Switzerland, with the NDC 44567-640-01.*
FDA Label Image

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 8 mg Per 250 mL Bag Image (Image 02)

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 8 mg Per 250 mL Bag Image (Image 02)
Label for Norepinephrine Bitartrate Injection, solution in 0.9% sodium chloride, 8 mg per 250 mL (32 mcg/mL) for intravenous use. The label includes a high alert medication warning, NDC 44567-641-01, storage instructions, and manufacturer WG Critical Care, LLC, made in Switzerland.*
FDA Label Image

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 16 mg Per 250 mL Bag Image (Image 03)

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 16 mg Per 250 mL Bag Image (Image 03)
Packaging label for Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, solution for intravenous use. The label states a total of 16 mg per 250 mL (64 mcg/mL) and includes storage instructions, single-dose container note, and manufacturer WG Critical Care, LLC. The product is identified as a high alert medication with an NDC of 44567-642-01.*
FDA Label Image

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 32 mg Per 250 mL Bag Image (Image 04)

Norepinephrine Bitartrate In 0.9% Sodium Chloride Injection 32 mg Per 250 mL Bag Image (Image 04)
Label for Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, 128 mcg/mL (32 mg per 250 mL) solution for intravenous use. The label highlights it as a high alert medication and specifies the concentration, usage warnings, and storage instructions. Manufactured for WG Critical Care, LLC, made in Switzerland, with the NDC 44567-643-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.